Ranbaxy Laboratories has reported results for third ended September 30, 2012.
The company has reported net profit of Rs 552.19 crore for the quarter as compared to a net loss of Rs 439.20 crore for the same quarter in the previous year. Total income of the company has increased by 5.60% at Rs 1527.36 crore for quarter under review as compared to Rs 1446.41 crore for the quarter ended September 30, 2011.
Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.
